Home -> Law Blog Directory -> Personal Injury Law Blogs -> Scottsdale Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Scottsdale Personal Injury LawyerWyeth Recalls Cold Medicine Due to Dosing Cup Issue
By Jenny Albano
Wyeth is recalling several brands of nonprescription cold medicine because they come with a dosing cup that does not mark the half-teaspoon level recommended for children aged 2 through 5 years old. According to the Wyeth spokesperson, there is nothing wrong with the product.
The cold medicines being recalled are: Robitussin Cough DM, Robitussin Cough & Cold CF, Robitussin Cough & Congestion, Robitussin Head & Chest Congestion PE, Robitussin Cough Sugar Free DM and Children's Dimetapp Cough & Chest Congestion
The company is recommending that consumers with children in the 2 through 5 age group not use the medicines until replacement products with a new dosage cup are available. That will probably begin in early November, and the new boxes will be marked to indicate the replacement.
The spokesman, Doug Petkas, says the recall and replacement will probably take a couple of months because their are millions of the products in stores now. But he stated that customers should not try and recieve a refund because there have been no injuries in relation to the recall.
For more information on this subject, please refer to our section on Defective and Dangerous Products.
Full post as published by Scottsdale Personal Injury Lawyer on November 02, 2007 (boomark / email).
Wyeth
to Pay Amputee $6.7 Million in Landmark Case
Mr. Brown Instant Coffee
Possible Melamine Contamination Prompts Canadian Agency to Issue Warning
Vicks Dayquil Cold & Flu Liquicaps Recalled
Vicks Dayquil Cold & Flu Liquicaps Recalled
Wyeth Sued Over Rapamune Transplant Drug
Illegal Marketing of Rapamune Sparks Lawsuit
Zicam Cold Remedies
FDA Advises "Don't Use"
Atlas Cold Storage
Income Trust to pay $40 million to settle a class action that claims misrepresented financial statements.

UCB cough medicine with hydrocodone linked to death, breathing problems
Could New Wyeth Layoffs Spell Trouble for Wyeth 401k Members
Hospitals Harm 1 in 15 Children with Medication Dosing Errors
FDA strongly recommends OTC cold medicines not be used in children under 2
Wyeth Investors Lose Out to the Pristiq Fumble









